Desvenlafaxine
- Product NDC
- 70771-1661
- 11-digit product format
- 707711661
- Labeler code
- 70771
- Product ID
- 70771-1661_64a7578c-3dfc-44ab-ab44-62a8256d8d3b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Desvenlafaxine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA204020
- Marketing category
- ANDA
- Marketing start
- 2022-11-30
- Marketing end
- 0000-00-00
- Substance
- DESVENLAFAXINE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70771-1661-3 | 70771166103 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1661-3) | 2022-11-30 | 0000-00-00 | No | No | Current |
| 70771-1661-9 | 70771166109 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1661-9) | 2022-11-30 | 0000-00-00 | No | No | Current |